Editor's Pick
The firm plans to present data from a large validation study of the Signal-C early detection test later this year as it contemplates approval.
In purchasing startup SolveBio, Precision for Medicine's QuartzBio saw an opportunity to augment its genomic and clinical data analytics during a growth phase.
Ampel will use the signature to develop FibroGene, a fibromyalgia blood test that the company expects to launch next year.
Foundation Medicine, Natera Launch Early Access for Clinical Personalized ctDNA Monitoring Test
Premium
The personalized and targeted tumor assay, also available for research use in clinical trials, provides a surrogate measure of tumor burden from blood samples.
NY Genome Center Team Harnesses Ultima Genomics Platform for High-Sensitivity ctDNA Sequencing
Premium
Taking advantage of the new platform's low sequencing cost, the researchers sequenced cell-free circulating DNA (ccfDNA) in plasma at high depth for sensitive cancer monitoring.